Mr. Schneider is a mechanical design engineer with over 20 years of engineering experience in the design of complex electromechanical prototypes and products. He earned a BS in mechanical engineering with Honors from the University of Maryland, College Park, and a MSE in mechanical engineering from Johns Hopkins University with a focus on haptics and medical robotics. In 2012, he founded Root3 Labs to focus on practical R&D for the medical device and defense industries.
The 6th annual Biohealth Capital Region (BHCR) Forum kicks off on October 19th. This year’s event will be held virtually and will bring together the top biotech and life science executives and expert speakers from across the industry, academia, healthcare, government, finance, and real estate development, among others.
Courtesy of Luke Daum, Chief Scientific Officer and Executive VP at Longhorn Vaccines and Diagnostics Good News – Featuring Johns Hopkins, Longhorn Vaccines and Diagnostics, and More… Across the country, [….]
Good News Stories of the Week – Featuring the Farmers, Dad Jokes, and More. Montgomery County, Maryland Farmers Band Together to Support Food Security With concerns about food supply chain [….]
Job Market for Postdocs Reflect New Challenges and Opportunities During COVID-19 The life science job market, both in academia and the commercial industry, was fiercely competitive before the coronavirus pandemic [….]
Six Johns Hopkins COVID-19 Programs that Reflect A Culture of Leadership from Clinical Research to Healthcare Innovation
Photo Credit: Will Kirk / Johns Hopkins University Good News Stories Emerging from the Capital Region Show Solidarity Amid Coronavirus Endless social media scrolls, 24/7 news channels, newspapers, and radio [….]
Top 10 Podcasts of 2019 from the BioHealth Capital Region Check out these Podcasts Featuring Some of the Top Biohealth Industry Leaders and Executives from the Region To say it [….]
Microsoft – Johns Hopkins Fast Forward Partner on AI Award Program
Germantown, MD-based Neuraly & Theraly Fibrosis Advance Clinical Parkinson’s and Alzheimer’s Candidates with $137.1M in Series B Financing Raised by Parent Company D&D Pharmatech
Neuraly Theraly Fibrosis raise $137.1M in Series B from Korean Parent Company DD Pharmatech